Life Sciences Business Development Trends for 2027

19 November 2026 | 13:00 CEST | Live Expert Panel | 45 minutes

AI is becoming part of how business development teams research prospects, identify opportunities and prepare outreach. At the same time, prospective clients can use AI tools to discover companies, compare capabilities and evaluate potential partners before making direct contact.

Add shifting market dynamics, evolving partnership priorities and pressure to demonstrate commercial value, and there are some serious questions to address when preparing your 2027 business development plan.

In this expert discussion, four professionals working across biotech, market intelligence, commercial strategy and health innovation partnerships will explore what these developments mean in practice.

Life Sciences Business Development Trends for 2026

What will we discuss?

1. Making AI useful for business development

Where can AI genuinely support prospect research, market intelligence, account prioritisation and outreach? We will discuss practical applications, their limitations and where human judgement remains essential.

2. When your prospective clients use AI to find and compare you

What happens when a potential client asks an AI assistant to identify suitable CROs, CDMOs, technology providers or specialist partners? We will explore what makes companies discoverable, how their capabilities are represented and why credible, accessible information matters.

3. Changing market dynamics and commercial opportunities

How are funding conditions, industry priorities, partnerships and customer expectations influencing business development? We will explore what companies should consider when selecting target markets, pursuing opportunities and allocating resources.

4. The growing importance of niche positioning

Can you convincingly explain why a specific customer should choose your company? We will discuss how clear specialisation, differentiated capabilities and substantiated claims can strengthen your commercial positioning.

5. Adapting your business development plan for 2027

How should these developments translate into practical decisions? We will bring the discussion together around target customers, positioning, marketing activities, outreach, partnerships and commercial priorities for the coming year.

Maryam Daneshpour, PhD, MBA

Biotech & Pharma Market Researcher
Maryam combines scientific expertise with business and market intelligence. Her work covers pharmaceutical and biotech pipelines, clinical trials, funding, competitive landscapes, regulatory developments and strategic transactions. With a PhD in Medical Biotechnology and an MBA, she helps translate complex scientific and commercial information into insights that support positioning, market understanding and business decisions.

Bilyana Petrova

Marketing & BD @ JPP
Bilyana works with life-sciences companies to connect commercial strategy with marketing and business development activities. Her work at JPP includes positioning, scientific communication and translating commercial priorities into practical marketing plans. She has co-led workshops on marketing planning and participated in industry discussions on communicating biotech innovation to potential customers, partners and investors.

Asier Sesma

Co-founder & COO | Invitrolize S.A.
Asier leads commercial operations at Invitrolize, a Luxembourg-based biotech spin-off of the Luxembourg Institute of Science and Technology (LIST). The company commercialises ALIsens®, a patented human in vitro alveolar model for respiratory sensitisation testing. Previously Head of LIST Ventures, Asier has experience translating research into deep-tech businesses. He brings a founder’s perspective on positioning and selling complex scientific solutions, developing commercial partnerships and building CRO networks.

Moderated by Andreea Munteanu

Community & Partnerships Director | Hive Services
Andreea works at the intersection of health innovation, strategic partnerships and ecosystem development. At Luxembourg-based Hive Services, she helps build connections between innovators, industry professionals, investors and commercial partners. With more than a decade of experience in communications and community building, she brings a perspective on how professional networks, strategic relationships and market access contribute to business growth.

Who should attend?

This webinar is intended for CEOs, founders, chief business officers, business development professionals and commercial or marketing leaders working in the life sciences.

It is particularly relevant for biotech companies, CROs, CDMOs, technology providers and specialist service companies preparing their commercial priorities for 2027.

Whether you are building a business development function, entering new markets or reviewing an established commercial approach, the discussion will help you identify which assumptions in your current plan deserve another look.

Register now

Is your business development plan ready for 2027?

Explore the trends affecting how life-sciences companies identify opportunities, attract potential customers and develop commercial partnerships.